Yahoo! Finance: XOMA NewsLatest Financial News for XOMA LTDXOMA to Present At the UBS Global Life Sciences Conference On September 22 (GlobeNewswire)- September 16, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080916/150464.html New Programs Added in Antibody Collaboration Between XOMA and Takeda (GlobeNewswire)- September 15, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080915/150354.html Xoma explores biotech partnership with Texas A&M (AP)- September 10, 2008 Biotechnology company Xoma Ltd. said Wednesday it has reached an agreement with Texas A&M University to codevelop biotech drugs.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080910/xoma_texas_a... Texas A&M University System and XOMA Sign Memorandum of Understanding (GlobeNewswire)- September 10, 2008 COLLEGE STATION, Texas and BERKELEY, Calif., Sept. 10, 2008 -- The Texas A&M University System and XOMA, Ltd , a leader in the discovery and development of therapeutic antibodies, today announced an agreement to explore options for the development and manufacture of antibodies and protein-based therapeutics for human and veterinary applications.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080910/150011.html Xoma wins $65M federal contract for botulism treatment (at bizjournals.com)- September 9, 2008http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128pjfkgd/*http://eastbay.bizjournals... XOMA Awarded $65 Million Biodefense Contract by NIAID to Advance Drug Candidates Against Botulism Toxins Into Clinical Trials (GlobeNewswire)- September 9, 2008 BERKELEY, Calif., Sept. 9, 2008 -- XOMA Ltd. today announced that it was awarded a $65 million multiple year contract from the National Institute of Allergy and Infectious Diseases , a component of the National Institutes of Health , to support XOMA's ongoing development of drug candidates towards clinical trials in the treatment of botulism poisoning, a potentially deadly muscle paralyzing disease.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080909/149985.html Xoma diabetes studies could lead to single monthly dose (at bizjournals.com)- September 8, 2008http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12hl862b2/*http://sanfrancisco.bizjou... XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Targeting Inflammatory Damage to Insulin-Producing Cells (GlobeNewswire)- September 8, 2008 ROME, Sept. 8, 2008 -- XOMA Ltd. announced interim data from two Phase 1 clinical studies of XOMA 052, an antibody drug candidate with an ultra high binding affinity of 300 femtomolar, which support a novel anti-inflammatory approach to Type 2 diabetes treatment that may preserve insulin-producing cells.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080908/149844.html Xoma says antibody lowers blood sugar in diabetics (at Reuters)- September 8, 2008http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=1165jh9eu/*http://www.reuters.com/... |